Depression and general medical health care expenditures increase with the degree of treatment-resistant depression. Disease management interventions for treatment-resistant depression that result in sustained remission early in the course of illness are most likely to be cost effective.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2004) studied this question.